The compounds covered in this piece GHK-Cu, KPV, GLP-1 agonists, NAD precursors, glutathione, Thymosin Alpha-1, low-dose MOTS-c, DSIP, intermittent Semax and Selank, and Tesamorelin do not have a receptor desensitization mechanism that justifies the universal 8-on, 4-off rule
Learn about our quality process Related products BPC-157/TB-500/GHK-Cu 10+10+50mg (GLOW blend 70mg) Summary Description: The GLOW Peptide Blend is a synthetic combination of three well-characterized regenerative peptides: BPC-157, TB-500, and GHK-Cu, each with complementary mechanisms that promote cellular repair, angiogenesis, and tissue remodeling
10.1186/s12943-021-01316-8 303 XiaY.GuM.WangJ.ZhangX.ShenT.ShiX.et al (2024)
It remains the only medication specifically approved for reducing excess visceral abdominal fat in HIV-infected patients with lipodystrophy